Remember When: The $4 generics battle was in full swing

Below-cost reimbursements are still a concern for pharmacists. More

POPULAR ON THE WEB

25 cities with the highest pharmacist salaries

Are community pharmacists an endangered species?

10 shocking things I've learned as a pharmacist

EDITOR'S CHOICE

Incidental Use and Disclosure of HIPAA Information

Not all violations are reportable—and some may not be considered a breach. Here's what you need to know. More

Inside The Latest Issue

This year's Top Drugs Remember When: The $4 generics battle was in full swing FDA approves lixisenatide for type 2 diabetes

January 03, 2017

Continuing education

Key cogs in the management of Parkinson's disease

Addressing unique medication adherence issues for patients with schizophrenia

Rheumatoid arthritis: Partnering for optimal care

Get the free app!

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us